#16
|
|||
|
|||
Äóìàëà,÷òî àíåìèÿ,ò.ê íåìíîãî ïîíèæåí ýðåòðîïîýòèí.Íî åå íåò.
Ïëîõîå ñàìî÷óâñòâèå,îñîáåííî ñâÿçàíû ïðîáëåìû ñ ãîëîâîé.(çðåíèå åäèíèöà, à âèæó ðàçìûòî ,êîãíþòèâíûå ñïîñîáíîñòè ñíèçèëèñü ). Íåâðîëîãè íè÷åãî íå íàçíà÷àþò,êðîìå êàðíåòèíà,ôåíèáóòà. Óçíàëà,÷òî ïî ýòîìó àíàëèçó ìîæíî îïðåäåëèòü åñòü ëè íàðóøåíèÿ,êîòîðûå ñïîñîáñòâóþò òàêèì ñèìòîìàì.Ïðàâäà,íå êàæäûé âðà÷ ñìîæåò ðàñøèôðîâàòü. Âîçìîæíî ÿ îøèáàþñü. |
#17
|
||||
|
||||
Ýðèòðîïîýòèí â íîðìå, òàê êàê 7.8 ~ 8, ìîæåò âàøè öèôðû äîëæíû áûòü âûøå è íàïðèìåð áîëåå 10, íî ýòî íóæíî îáñóäèòü ñ î÷íûìè ñïåöèàëèñòàìè ïî òðàíñïëàíòàöèè
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#18
|
|||
|
|||
Äîáðûé äåíü.
Ñäàëà ÎÆÑÑ 56,1 (46-76) ìêìîëü/ë ÑÛ ÆÅËÅÇÎ 9.06.(5.83-34,5) ÐÀÑÑ×ÈÒÀËÈ %ÍÀÑÛÙ ÒÐÀÍÑÔÅÐÈÍÀ= 16 Îçíà÷àåò ëè ýòî ,÷òî íå õâàòàåò æåëåçà â îðãàíèçìå,ïðè òîì ,÷òî ôåððåòèí 200? |
#19
|
||||
|
||||
A serum ferritin threshold of <100 μg/L or TSAT < 20% can be considered diagnostic for iron deficiency in CHF, CKD, and IBD.
If serum ferritin is 100–300 μg/L, TSAT < 20% is required to confirm iron deficiency. TSAT = % ÍÀÑÛÙ ÒÐÀÍÑÔÅÐÈÍÀ
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#20
|
|||
|
|||
Ò.å åñëè ó ìåíÿ ôåððåòèí 200,à TSAT 16%,ïðè ÑÊÔ 35(ÕÏÁ),òî ôåððåòèí ëîæíî çàâûøåí è èäåò íåõâàòêà æåëåçà?
Èëè ÿ ÷òî-òî íå ïîíÿëà? |
#21
|
||||
|
||||
ó âàñ äåôèöèò æåëåçà, ôåððèòèí ëîæíî-íîðìàëåí, òàê êàê çàâûøåí åòî áîëåå 300-500
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#22
|
|||
|
|||
ß ìîãó ïðèíèìàòü æåëåçî,íàïðèìåð, hema-pleks.?
|
|
#23
|
||||
|
||||
ìîæåòå, íî îíî ó âàñ ìîæåò è íå óñâîèòüñÿ, âðîäå áû ñèäåðàë ïðè ÕÏÍ óñâàèâàåòñÿ âíóòðü
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |